Showing results (2281-2290 of 5,261) with videos related to

Sort By:
Pageof 527
Oncology|December 20, 2017
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pyloriTeppei Adachi, Shigenaga Matsui, Tomohiro Watanabe, et al.
Oncology|December 20, 2017
The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal CancersSatoshi Ogawa, Tatsuya Ishii, Kosuke Minaga, et al.
Oncology|December 20, 2017
Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous NeoplasmKen Kamata, Mamoru Takenaka, Atsushi Nakai, et al.
Oncology|September 18, 2017
Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event EndpointsFrancesca De Felice, Maria Teresa Martinetti, Simone Orelli, et al.
Oncology|September 4, 2020
Comparison of Preoperative Positron Emission Tomography/Computed Tomography with Panscopy and Ultrasound in Patients with Head and Neck CancerAmir M Salehi, Lena Norberg-Spaak, Simon Vallin, et al.
Oncology|September 6, 2020
The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical CancerGiorgia Perniola, Federica Tomao, Marialida Graziano, et al.
Oncology|September 7, 2020
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI TreatmentJeng-Sen Tseng, Kuo-Hsuan Hsu, Zhe-Rong Zheng, et al.
Oncology|September 9, 2020
Clinical Significance of Conversion Surgery for Gastric Cancer with Peritoneal Dissemination: A Retrospective StudyTakaaki Arigami, Daisuke Matsushita, Keishi Okubo, et al.
Oncology|November 18, 2020
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib TreatmentDaiki Yamashige, Yusuke Kawamura, Masahiro Kobayashi, et al.
Oncology|December 25, 2022
Clinical Efficacy and Safety of Nivolumab in Malignant Non-Pleural Mesothelioma: A Multicenter, Open-Label, Single-Arm, Japanese Phase II Trial (Viola) ProtocolKozo Kuribayashi, Masataka Igeta, Takashi Daimon, et al.
Pageof 527